Anupam Rasayan India Limited , a prominent player in the Indian chemical industry, has recently disclosed a significant development involving one of its promoters. Mona Anandbhai Desai, a key promoter of the company, has pledged a portion of her shareholding to secure a loan. This move has caught the attention of market observers and investors alike.

Details of the Share Pledge

Promoter's Shareholding

The pledge transaction was executed on June 19, 2025, with STCI Finance Limited as the beneficiary. This financial maneuver by the promoter is aimed at securing a loan, though the specific amount and terms of the loan have not been disclosed in the available information.

Regulatory Compliance

The company has duly reported this share pledge in compliance with the Securities and Exchange Board of India (SEBI) regulations governing substantial acquisition of shares and takeovers. Such disclosures are mandatory to ensure transparency and keep shareholders informed about significant changes in promoter holdings.

Company Background

Anupam Rasayan India Limited is a well-known entity in the Indian stock market, listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

This development underscores the importance of monitoring promoter activities in listed companies, as such actions can potentially impact investor sentiment and market dynamics. Shareholders and potential investors may want to keep a close eye on any further developments or disclosures from the company regarding this transaction.

Anupam Rasayan India Limited , a leading specialty chemicals company, has reported exceptional financial results for the second quarter, showcasing robust growth across key metrics.

Strong Revenue Growth

The company delivered a stellar performance with consolidated revenue from operations of ₹731.40 crore in Q2, marking a remarkable 148.80% year-on-year growth and a 50.50% sequential increase. For the first half, consolidated revenue reached ₹1,217.20 crore, representing an impressive 122.10% year-on-year growth.

Segment-wise Performance

Life Science Related Specialty Chemicals continued to be the primary revenue driver, contributing 84% of total revenue in H1. Within this segment:

• The Pharma segment accounted for 23% and registered a strong 201% YoY growth during H1, driven by new product launches and scale-up of recently commercialized molecules.
• Performance Materials contributed 16% of total revenue in H1, with revenue growing by 306% YoY, supported by the ramp-up of newly launched polymer molecules.

Profitability and Margins

The company reported consolidated EBITDA margins of approximately 19.50% in Q2 and 25.50% for H1. These margins were slightly subdued due to some dispatches made from older inventory. Management expects margins to normalize from Q3 onwards as new contracts and pricing structures take effect.

Order Book and Future Outlook

Anupam Rasayan's order book remains healthy at around ₹14,646.00 crore, spread over 5-7 years. The company expects these orders to contribute approximately ₹450.00 crore in revenue. Management has guided for over 50% revenue growth, largely attributed to recovery in agrochemicals sales and growth in polymer and pharma segments.

Geographical Performance

The US market has shown phenomenal growth and continues to be a key growth driver for the company. Importantly, the majority of Anupam Rasayan's products fall under the exempt category for recently imposed US tariffs, ensuring that exports remain unaffected by cost pressures.

Working Capital Management

The company has made significant progress in optimizing its balance sheet and improving working capital efficiency:

Management expects to further reduce working capital days to approximately 200 in the near term.

Debt Reduction

With the receipt of ₹277.50 crore from warrants in July, the company used ₹175.00 crore towards repayment of term debt, resulting in a net debt of ₹730.00 crore at the consolidated level.

Anand Desai, Managing Director of Anupam Rasayan, commented on the results: "This quarter truly reflects the best of Anupam Rasayan—our agility, customer trust, and execution strength—supported by a favorable industry environment and renewed momentum across global markets."

The company's strong performance in Q2 positions it well for sustained growth and profitability in the coming periods, reflecting the resilience of its business model, strong customer relationships, and operational excellence.